Two Approvals Underscore Biotech's Pipeline Quality
Source: Streetwise Reports  (1/29/20)
The green lights and their implications are discussed in an H.C. Wainwright & Co. report. More >

Accuray Shares Rise on Q2 Earnings, Increased Backlog and Raised FY/20 EBITDA Guidance
Source: Streetwise Reports  (1/29/20)
Shares of Accuray traded 15% higher today after the company reported Q2/20 financial results. More >

California Gold: Two U.S. Hemp Revenue Streams Coming Online This Quarter
Source: Peter Epstein for Streetwise Reports  (1/29/20)
Peter Epstein of Epstein Research discusses recent developments at the company. More >

Acceleron Shares Open 50% Higher on Phase 2 PAH Trial Data
Source: Streetwise Reports  (1/28/20)
Acceleron Pharma's shares established a new 52-week high after the company reported that sotatercept achieved both primary and secondary endpoints in the Phase 2 PULSAR study in patients with pulmonary arterial hypertension. More >

Inovio Pharma Awarded $9M Development Grant for Coronavirus Vaccine
Source: Streetwise Reports  (1/27/20)
Inovio Pharmaceuticals' shares rose 30%, setting a new 52-week high price, after the firm reported it received a grant of up to $9 million to develop a vaccine against the coronavirus. More >

Healthcare Tech Firm Now Has 90,000 Patients on Telemedicine Portal
Source: Streetwise Reports  (1/24/20)
The company continues to evolve this digital offering as well. More >

Life Sciences Firm Partners to Develop, Sell Canine Supplement
Source: Streetwise Reports  (1/24/20)
The product contains the firm's OxC-betaâ„¢ supplement. More >

Imaging System Developer Outlines Plan for 2020
Source: Streetwise Reports  (1/24/20)
The company continues to advance its device toward commercialization. More >

Premier Health Group Update: Charting 'Strongly Bullish' Movement
Source: Clive Maund for Streetwise Reports  (1/24/20)
Technical analyst Clive Maund examines this potential of the company's stock. More >

eHealth Shares Rise 25% After Achieving 100% Increase in Quarterly Medicare Advantage Sales
Source: Streetwise Reports  (1/24/20)
Online medical exchange operator eHealth Inc.'s shares traded higher after the firm reported preliminary financial results for Q4/19 and FY/19. The company advised that both quarterly and annual revenues exceeded prior estimates. More >

Co-Diagnostics Utilizes CoPrimer Platform to Design New Coronavirus Detection Test
Source: Streetwise Reports  (1/23/20)
Molecular diagnostics company Co-Diagnostics' shares opened more than 144% higher after the firm reported it has designed a test for virus detection of the new coronavirus, 2019-nCoV, using its CoPrimerâ„¢ platform. More >

Neurotrope's Shares Double on Phase 2 Alzheimer's Study Data and $2.7 Million NIH Grant
Source: Streetwise Reports  (1/22/20)
Neurotrope's shares traded higher today after reporting results from its Phase 2 "203" clinical trial of Byrostatin-1 for treatment of moderately severe to severe Alzheimer's patients. The firm has also been awarded a $2.7 million grant from the National Institutes of Health to conduct additional clinical research for patients with advanced Alzheimer's disease. More >

Biopharma Shows 'Good Start to 2020 News Flow'
Source: Streetwise Reports  (1/21/20)
The two developments that already took place this year are addressed in an H.C. Wainwright & Co. report. More >

Genprex Shares Soar 250% on FDA Fast Track Designation for Lung Cancer Drug
Source: Streetwise Reports  (1/21/20)
Genprex's shares spiked 380% higher in morning trading as the company reported that the FDA granted Fast Track Designation for its Oncoprex immunogene therapy in combination with EGFR inhibitor osimertinib. More >

InMed Shares Trade Up 25% After Becoming First to Advance Cannabinol into Clinical Trials
Source: Streetwise Reports  (1/20/20)
InMed Pharmaceuticals shares traded 25% higher after reporting that it is the first to advance cannabinol into therapeutic clinical trials. More >

NantKwest Shares Jump More than 50% Following JP Morgan Healthcare Conference Presentation
Source: Streetwise Reports  (1/16/20)
Shares of NantKwest Inc. spiked as much as 85% higher in mid-morning trading setting a new 52-week high price after the company reported a series of positive results at the 38th J.P. Morgan Healthcare Conference in San Francisco. The firm reported that complete responses were noted in as many as six different multiple tumor types when "natural killer" cells and T cells are activated simultaneously. More >

Biotech Announces Deal with Bayer on Non-Hormonal Contraception
Source: Streetwise Reports  (1/15/20)
Details of the arrangement and an update on the company's pipeline are provided in a Dawson James report. More >

Disruptive Technology Poised to Deliver Significant Advancement in Bladder Cancer Detection
Source: Chris Temple for Streetwise Reports  (1/14/20)
Chris Temple, editor and publisher of The National Investor, explains why he recommends this small-cap as a Buy. More >

Two Analysts See Company as a Buy for 'Game-Changing' Potential in Bladder Cancer Detection and Surgery
Source: Streetwise Reports  (1/14/20)
The disruptive technology is 'poised to deliver significant advancement in bladder cancer detection.' More >

Healthcare Company Closes Acquisition of Telehealth Firm
Source: Streetwise Reports  (1/14/20)
The transaction brings numerous existing partnerships and digital technologies. More >

Transenterix Shares Trade Up 25% on FDA Filing for First Machine Vision System in Robotic Surgery
Source: Streetwise Reports  (1/14/20)
Shares of Transenterix opened 50% higher after the company reported that it has submitted a 510(k) submission to the FDA for the first machine vision system for use in robotic surgery. More >

Adaptimmune Shares Triple as SPEAR T-cell Platform Delivers Initial Responses in Four Solid Tumor Indications
Source: Streetwise Reports  (1/13/20)
Shares of Adaptimmune Therapeutics more than tripled in value after the company reported that its SPEAR T-cell platform delivered positive initial responses in four different solid tumor indications. More >

Telemedicine Tech Firm Garners Five New US Clients
Source: Streetwise Reports  (1/10/20)
With these contracts, the company extends its geographic footprint to an additional county. More >

Life Sciences Firm Upgrades to OTCQB Venture Market
Source: Streetwise Reports  (1/10/20)
This is a significant achievement of this developing company. More >

Developer Completes Design Verification of Imaging Device for Bladder Cancer
Source: Streetwise Reports  (1/10/20)
In doing so, it gets one step closer to market approval from U.S. regulators. More >